Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Research from T.E. Delea and co-authors yields new data on asthma
February 24th, 2009
In this recently published study, investigators in the United States conducted a study "To assess the association between adherence with fluticasone propionate/salmeterol combination (FSC) product in a single inhaler and asthma care utilization and costs in asthma patients in typical US clinical practice. Retrospective longitudinal analysis using linked medical and pharmacy claims from a managed care database representing >70 US health plans." "Subjects included those with two prescriptions for FSC after January 1, 2000 (first prescription 'index date') and diagnosis of asthma. Follow-up was defined as time from index date to disenrollment or discontinuation of FSC...
Source: Cancer Weekly (2009-02-24)
|
